Penumbra Valuation Multiples

Penumbra Overview

About Penumbra

Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.

Founded

2004

HQ

Employees

4.7K

Website

penumbrainc.com

Sectors

Medical DevicesBioTechLongevity

Financials (LTM)

Revenue: $1B

EBITDA: $281M

EV

$13B

Valuation Multiples

Multiples.vc

Start free trial

Penumbra Financials

Penumbra reported last 12-month revenue of $1B and EBITDA of $281M.

In the same LTM period, Penumbra generated $985M in gross profit, $281M in EBITDA, and $164M in net income.

Penumbra P&L

In the most recent fiscal year, Penumbra reported revenue of $1B and EBITDA of $267M.

Penumbra expects next 12-month revenue of XXX and NTM EBITDA of XXX

Penumbra Stock Performance

Penumbra has current market cap of $13B, and enterprise value of $13B.

Penumbra's stock price is $329.77.

Penumbra Valuation Multiples

Penumbra trades at 8.7x EV/Revenue multiple, and 45.0x EV/EBITDA.

Penumbra Financial Valuation Multiples

As of April 13, 2026, Penumbra has market cap of $13B and EV of $13B.

Equity research analysts estimate Penumbra's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Penumbra has a P/E ratio of 78.8x.

Penumbra Margins & Growth Rates

Penumbra's revenue in the last 12 month grew by 13%.

Penumbra's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.

Penumbra's rule of 40 is 33% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Penumbra's rule of X is 53% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Penumbra Public Comps

See public comps and valuation multiples for other Medical Devices comps.

Penumbra M&A Activity

Penumbra acquired XXX companies to date.

Last acquisition by Penumbra was on XXXXXXXX, XXXXX. Penumbra acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Penumbra Investment Activity

Penumbra invested in XXX companies to date.

Penumbra made its latest investment on XXXXXXXX, XXXXX. Penumbra invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).